Status:
COMPLETED
Emotions in Multiple Sclerosis
Lead Sponsor:
Lille Catholic University
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
Through this study, a group composed of multiple sclerosis patients will be compared to a healthy volunteers group to determine if the positive emotions recognitions is preserved in the first group.
Detailed Description
Different studies have highlighted the specific deficiency concerning emotions recognition in multiple sclerosis. Patients with multiple sclerosis are reported to have more difficulty recognising nega...
Eligibility Criteria
Inclusion
- Male or female between 18 and 55 years old.
- Understand and able to express themselves in French.
- EXPERIMENTAL GROUP :
- Relapsing-remitting form (RRMS)
- With an EDSS \< 4 (Expanded Disability Status Scale)
- No significant motor, cerebellar or somatosensory disorders of the upper limbs or visual disorders (EDSS specific parameter \<2)
- No flare-up in the last 6 weeks
- No corticosteroids taken in the last 4 weeks
- CONTROL GROUP :
- Lack of global cognitive deterioration (according to Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) standards).
- Gender, age and education level matching to the multiple sclerosis patients
- Understanding and signing the informed consent and information letter regarding participation in the study.
- Benefiting from health insurance coverage.
Exclusion
- Persons with previous neurological pathologies, head trauma with loss of consciousness, psychiatric pathologies, serious general affections, perceptive or dysarthric disorders preventing verbal communication or reading,
- People with sensory disorders (visual and auditory) that interfere with the performance of neuropsychological tests;
- Treatment with psychotropic drugs (except benzodiazepines and hypnotics).
- Refusal to participate after clear and fair information about the study.
- Major persons under guardianship, under judicial protection, persons deprived of liberty.
- Pregnant or breastfeeding women
Key Trial Info
Start Date :
June 23 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 25 2025
Estimated Enrollment :
101 Patients enrolled
Trial Details
Trial ID
NCT04804787
Start Date
June 23 2021
End Date
February 25 2025
Last Update
December 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Saint-Vincent de Paul
Lille, France, 59000